References
- Beam A, Kunkel H, Slater R. The problem of chronic liver disease in young women. Am J Med 1956; 21: 3–15
- Saint E, King W, Joske R, Finckh E. The course of infectious hepatitis with special reference to prognosis and the chronic stage. Austr Ann Med 1953; 2: 113–127
- Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362
- Kuo G, Choo Q, Alter H, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364
- Esteban J, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–297
- Lenzi M, Ballardini G, Fusconi M, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 1: 258–259
- McFarlane I, Smith H, Johnson P, Bray G, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?. Lancet 1990; 1: 754–757
- Soloway R, Summerskill W, Baggenstoss A, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastro-enterology 1972; 63: 820–833
- Robertson D, Zhang S, Guy E, Wright R. Persistent measles virus genome in autoimmune chronic active hepatitis. Lancet 1987; 2: 9–11
- Olsson R, Lindberg J, Weiland O, Nilsson L. Members of the Swedish internal medicine liver club and clinics for infectious diseases. Chronic active hepatitis in Sweden. The etiologic spectrum, clinical presentation and laboratory profile. Scand J Gas-troenterol 1988; 23: 463–470
- Alter H, Purcell R, Shih J, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. n. Engl J Med 1989; 321: 1494–1500
- Weiner A, Kuo G, Bradley D, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990; 1: 1–3
- Vento S, Di Perri G, Garofano T, et al. Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 1989; 2: 926